Summary

The global Straight Tube Thoracic Aortic Stent Graft System market is projected to grow from US$ 649 million in 2025 to US$ 1013 million by 2032, at a CAGR of 6.6% (2026-2032), driven by critical product segments and diverse end‑use applications. Straight Tube Thoracic Aortic Stent Graft System refers to a catheter-delivered, tube-shaped and non-branched implant system used in thoracic endovascular aortic repair. A complete system comprises a self-expanding covered stent, a dedicated delivery catheter and deployment-control components. The implant typically combines a nitinol or stainless-steel framework with a polyester or expanded polytetrafluoroethylene graft and radiopaque markers. Commercial systems generally cover nominal diameters of approximately 16–46 mm, covered lengths of about 60–260 mm and delivery profiles concentrated around 18–24 Fr, with selected low-profile systems reaching 18 Fr or below. The research scope covers cylindrical, tapered, reverse-tapered and thoracic extension configurations, with or without a proximal bare stent, implanted through a vascular access route into the aortic arch or descending thoracic aorta. Their principal functions are to exclude aneurysms or ruptures, seal dissection entry tears, restore true-lumen flow and reinforce diseased aortic segments. Major indications include thoracic aortic aneurysm, Stanford type B aortic dissection, traumatic thoracic aortic injury, intramural hematoma, penetrating atherosclerotic ulcer and related thoracic aortic lesions. Key Findings In 2025, global Straight Tube Thoracic Aortic Stent Graft System production reached approximately 75.71 K Units, with an average global market price of around US$ 8,571 per unit. Non-branched tube-type systems remain the volume core of TEVAR for descending thoracic aortic disease Stanford type B dissection and descending thoracic aneurysm are the principal demand-generating indications worldwide Commercial diameters generally span about 16–46 mm while low-profile delivery systems increasingly reach 18 Fr or below Market Trends Product development is shifting from basic aneurysm exclusion toward pathology-specific control, lower procedural trauma and more predictable aortic remodeling. Key upgrades include lower-profile hydrophilic delivery sheaths, staged or controlled deployment, tip-capture mechanisms, repositioning or angulation control, reduced distal radial force, anti-shortening structures and broader tapered configurations for dissection anatomy. Longer grafts and selectively perforated distal sections are being introduced to improve true-lumen expansion while managing spinal-cord perfusion risk. Manufacturers are also optimizing graft porosity, suture durability, radiopaque-marker layouts and proximal sealing structures to reduce bird-beak formation, endoleak and stent-graft-induced new entry. Hospitals increasingly value complete size matrices, immediate emergency inventory, simplified deployment and compatibility with hybrid operating rooms rather than isolated implant specifications. Over the longer term, CTA-based sizing, digital procedural planning, patient-specific simulation, post-market imaging analysis and integration with adjunctive bare stents will become more closely connected with product sales. Straight tube systems will remain the procedural workhorse, while branched and fenestrated devices address anatomies requiring supra-aortic branch preservation. Market Dynamics Drivers Demand is supported by population aging, improved CT detection of aortic disease, expansion of specialist aortic centers and the continuing substitution of open repair with less invasive endovascular treatment in anatomically suitable patients. Clinical guidance from the Society for Vascular Surgery and the Society of Thoracic Surgeons supports TEVAR in descending thoracic aneurysm and complicated type B dissection under appropriate conditions. Lower-profile devices expand eligibility among patients with small, calcified or tortuous access vessels, while better deployment control reduces procedural uncertainty. Demand is also generated by residual or recurrent disease after prior aortic surgery, traumatic injury, penetrating ulcers, intramural hematoma and emergency rupture. Broader reimbursement coverage, increasing physician training and the localization of high-value aortic devices in China and other emerging markets further support unit growth. Restraints Adoption remains constrained by demanding anatomy and the need for adequate proximal and distal landing zones. Severe arch angulation, extensive calcification, thrombus, small access arteries, connective-tissue disorders and disease involving major branch vessels can limit the use of standard tube-type systems. Clinical risks include endoleak, migration, retrograde type A dissection, spinal-cord ischemia, stroke, access-vessel injury and distal stent-graft-induced new entry. Patients require lifelong imaging surveillance, adding downstream healthcare costs and making long-term durability evidence important to purchasing decisions. Product development also requires substantial investment in fatigue testing, biocompatibility, sterilization validation, clinical trials and post-market surveillance. In price-controlled markets, declining tender or listing prices may improve access but compress margins and reduce the economic attractiveness of maintaining a large inventory of diameters, lengths and taper combinations. Opportunities The largest product opportunities lie in low-profile systems at or below 18 Fr, long-length and large-taper configurations for dissection, low-radial-force distal designs and systems providing accurate staged deployment. Wider diameter and length coverage can reduce the need to combine multiple grafts, potentially lowering procedure time and type III endoleak risk. Emerging-market hospitals need reliable, standardized tube-type systems before adopting more complex branched platforms, creating opportunities for manufacturers with local regulatory, training and service capabilities. Additional value can be captured through CTA planning, emergency inventory programs, proctoring, case support and bundled guidewire, sheath, balloon and adjunctive bare-stent solutions. Localized manufacturing in China, South Korea and other Asian markets can improve price competitiveness, while established suppliers can defend premium positioning through long-term clinical evidence, controlled deployment, full-size portfolios and international regulatory approvals. Challenges Manufacturers must balance conformability, sealing force and fixation strength against the risk of aortic-wall injury and new dissection. Small changes in nitinol heat treatment, stent geometry, graft permeability, suture tension or crimping can materially affect fatigue performance and deployment accuracy, creating high process-control requirements. A broad product matrix also increases inventory, validation and expiration-management costs. Regulatory expectations for long-term durability, rare adverse-event detection and post-market surveillance continue to rise, while recalls can quickly disrupt hospital procurement and regional market access. Competitive pressure is intensifying as Chinese manufacturers move from conventional tube grafts toward low-profile, long-segment and dissection-specific products. At the same time, centralized procurement and price-governance policies are narrowing room for distributor markups, forcing manufacturers to improve direct coverage, clinical support and supply-chain efficiency without compromising emergency availability. Industry Chain Analysis The upstream segment supplies medical-grade nitinol tubing or wire, stainless steel, woven polyester, ePTFE membranes, platinum-iridium or gold radiopaque markers, sutures, catheter polymers, hydrophilic coatings and sterilization packaging. Midstream manufacturing includes stent laser cutting or wire forming, electropolishing, heat setting, graft weaving or membrane processing, stent-graft sewing or bonding, marker attachment, catheter extrusion, cleanroom assembly and deployment-system integration. Critical validation covers radial force, fatigue, corrosion, graft permeability, tensile strength, dimensional accuracy, delivery and release performance, biocompatibility, sterilization and shelf life. Downstream participants include vascular-surgery, cardiovascular-surgery and interventional departments, tertiary hospitals, regional aortic centers, distributors, imaging-planning teams and reimbursement agencies. Value is created less through raw-material consumption than through implant design, delivery control, clinical evidence, regulatory approval, size-matrix completeness, physician training and dependable emergency supply. Post-implant CTA surveillance and adverse-event reporting feed back into product iteration and risk management, making clinical-service capability an integral part of the industrial chain. Segment Insights By graft material, polyester and ePTFE are the principal categories, with selection affecting permeability, thickness, flexibility and sealing behavior. By geometry, the market can be divided into cylindrical, tapered, reverse-tapered and thoracic extension grafts. Cylindrical products serve relatively uniform descending-aortic anatomy, whereas tapered products better match the distal narrowing commonly observed in dissection. Additional useful classifications include proximal bare-stent versus fully covered fixation, standard versus long-length systems, delivery profile of 18 Fr or below, 19–22 Fr and 23 Fr or above, and nominal diameter below 26 mm, 26–34 mm, 35–42 mm and above 42 mm. Tube-type systems remain the largest-volume configuration because they offer broad availability, standardized deployment and extensive use in descending thoracic aneurysm and type B dissection. Product value is migrating toward low-profile access, larger taper ranges, longer coverage and controlled deployment rather than a simple change in implant material. Commercial specifications from GORE, Cook Medical and MicroPort Endovascular illustrate the breadth of diameter, length and delivery options now required. Downstream Market Opportunities Stanford type B dissection represents a particularly important unit-demand opportunity in China and parts of Asia, where clinicians require tapered, long-segment, conformable systems with controlled radial force and options for adjunctive distal bare-stent support. Thoracic aneurysm treatment is more prominent among aging populations in North America, Europe and Japan, supporting demand for durable sealing, large-diameter availability and long-term surveillance evidence. Traumatic aortic injury, pseudoaneurysm and rupture are lower-frequency but time-critical applications in which immediate inventory, compact delivery profiles and rapid, predictable deployment are decisive. Penetrating atherosclerotic ulcer and intramural hematoma expand the addressable acute-aortic-syndrome population when intervention is clinically indicated. The principal customers are tertiary hospitals, regional aortic centers and cardiovascular programs equipped with hybrid operating rooms, advanced CTA planning and multidisciplinary teams. Suppliers able to provide full-size emergency inventories, procedural training and rapid case-planning support can gain an advantage beyond the implant itself. Regional Insights North America and Europe form the largest established value pool, supported by mature TEVAR adoption, specialist centers, reimbursement systems and long-term clinical evidence for products from Medtronic, W. L. Gore, Terumo Aortic and Cook Medical. Japan is a highly regulated, clinically mature market with demand for conformability and smaller-access solutions, while South Korea maintains a regional manufacturing presence through S&G Biotech. China combines substantial type B dissection demand with rapid domestic substitution led by MicroPort Endovascular, LifeTech Scientific, APT Medical and Beijing Percutek Therapeutics. Pricing pressure is materially stronger in China: the National Healthcare Security Administration reported that 12 domestic and international companies reset thoracic stent-graft terminal listing prices in 2024, with the publicly reported category quotations falling below RMB 80,000. Southeast Asia, Latin America and the Middle East remain import-oriented growth markets where regulatory registration, physician training and distributor capability determine commercial access. Product availability and approved indications vary significantly by country, requiring regional rather than purely global portfolio assessment. Competitive Landscape Analysis The global core consists of Medtronic, W. L. Gore & Associates, Terumo Aortic and Cook Medical, which compete through clinical evidence, delivery control, conformability, broad sizing portfolios and global training networks. Artivion participates through the E-vita Thoracic 3G platform in selected markets. The principal Chinese tube-type competitors are MicroPort Endovascular with Hercules and Talos, LifeTech Scientific with Ankura, APT Medical with RescSeal and Beijing Percutek Therapeutics with the Tianyi system; Aortec Medical Technology remains a regional specialist. SB-KAWASUMI’s Najuta provides straight and tapered sizes but is primarily positioned as a semi-custom, frequently fenestrated solution, placing it in the extended rather than core tube-type pool. Shanghai INT Medical Instruments is more directly associated with branched and hybrid aortic solutions, including the acquired or affiliated Hangzhou Endonom platform, and should be treated as an adjacent participant. S&G Biotech and INVAMED add regional competition. Competitive advantage depends on deployment precision, low-profile access, dissection-specific geometry, evidence quality, emergency inventory, regulatory coverage, hospital access and the ability to operate profitably under tightening price controls. Report Scope This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Straight Tube Thoracic Aortic Stent Graft System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers. By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern. Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed. Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths. A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand. Market Segmentation By Company Medtronic W. L. Gore & Associates Terumo Cook Medical Artivion SB-KAWASUMI LABORATORIES MicroPort Endovascular MedTech APT Medical LifeTech Scientific Corporation Beijing Percutek Therapeutics Aortec Medical Technology Shanghai INT Medical Instruments Segment by Type Polyester ePTFE Other Segment by Proximal Structure Covered Stent With Bare Segments Covered Stent Without Bare Segments Segment by Diameter Diameter<30mm Diameter 30-40mm Diameter>40mm Segment by Application Thoracic Aortic Aneurysm Stanford B-Type Aortic Dissection Traumatic Injury of Thoracic Aorta Aortic Intramural Hematoma Other Sales by Region North America U.S. Canada Mexico Asia-Pacific China Japan South Korea India China Taiwan Southeast Asia (Indonesia, Vietnam, Thailand) Europe Germany France U.K. Italy Russia Central and South America Brazil Argentina Rest of Central and South America Middle East, Africa Turkey Egypt GCC Countries South Africa Chapter Outline Chapter 1: Defines the Straight Tube Thoracic Aortic Stent Graft System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies Chapter 14: Actionable conclusions and strategic recommendations. Why This Report Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to: Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5). Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence. Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11). Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13). Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Straight Tube Thoracic Aortic Stent Graft System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Straight Tube Thoracic Aortic Stent Graft System Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Polyester
1.2.3 ePTFE
1.2.4 Other
1.3 Market Segmentation by Proximal Structure
1.3.1 Global Straight Tube Thoracic Aortic Stent Graft System Market Size by Proximal Structure, 2021 vs 2025 vs 2032
1.3.2 Covered Stent With Bare Segments
1.3.3 Covered Stent Without Bare Segments
1.4 Market Segmentation by Diameter
1.4.1 Global Straight Tube Thoracic Aortic Stent Graft System Market Size by Diameter, 2021 vs 2025 vs 2032
1.4.2 Diameter<30mm
1.4.3 Diameter 30-40mm
1.4.4 Diameter>40mm
1.5 Market Segmentation by Application
1.5.1 Global Straight Tube Thoracic Aortic Stent Graft System Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Thoracic Aortic Aneurysm
1.5.3 Stanford B-Type Aortic Dissection
1.5.4 Traumatic Injury of Thoracic Aorta
1.5.5 Aortic Intramural Hematoma
1.5.6 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Straight Tube Thoracic Aortic Stent Graft System Revenue Estimates and Forecasts (2021-2032)
2.2 Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Straight Tube Thoracic Aortic Stent Graft System Sales Estimates and Forecasts (2021-2032)
2.4 Global Straight Tube Thoracic Aortic Stent Graft System Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Straight Tube Thoracic Aortic Stent Graft System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Polyester: Market Share by Key Manufacturers
3.5.2 ePTFE: Market Share by Key Manufacturers
3.5.3 Other: Market Share by Key Manufacturers
3.6 Global Straight Tube Thoracic Aortic Stent Graft System Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales Performance by Type
4.1.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Type (2021-2032)
4.1.2 Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Straight Tube Thoracic Aortic Stent Graft System Sales Performance by Proximal Structure
4.2.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Proximal Structure (2021-2032)
4.2.2 Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Proximal Structure (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Proximal Structure (2021-2032)
4.3 Global Straight Tube Thoracic Aortic Stent Graft System Sales Performance by Diameter
4.3.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Diameter (2021-2032)
4.3.2 Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Diameter (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Diameter (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Straight Tube Thoracic Aortic Stent Graft System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Straight Tube Thoracic Aortic Stent Graft System Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Straight Tube Thoracic Aortic Stent Graft System Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Straight Tube Thoracic Aortic Stent Graft System Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Straight Tube Thoracic Aortic Stent Graft System Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Straight Tube Thoracic Aortic Stent Graft System Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Straight Tube Thoracic Aortic Stent Graft System Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.1.4 Medtronic Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Medtronic Straight Tube Thoracic Aortic Stent Graft System Sales by Product in 2025
11.1.6 Medtronic Straight Tube Thoracic Aortic Stent Graft System Sales by Application in 2025
11.1.7 Medtronic Straight Tube Thoracic Aortic Stent Graft System Sales by Geographic Area in 2025
11.1.8 Medtronic Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 W. L. Gore & Associates
11.2.1 W. L. Gore & Associates Corporation Information
11.2.2 W. L. Gore & Associates Business Overview
11.2.3 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.2.4 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System Sales by Product in 2025
11.2.6 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System Sales by Application in 2025
11.2.7 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System Sales by Geographic Area in 2025
11.2.8 W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
11.2.9 W. L. Gore & Associates Recent Developments
11.3 Terumo
11.3.1 Terumo Corporation Information
11.3.2 Terumo Business Overview
11.3.3 Terumo Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.3.4 Terumo Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Terumo Straight Tube Thoracic Aortic Stent Graft System Sales by Product in 2025
11.3.6 Terumo Straight Tube Thoracic Aortic Stent Graft System Sales by Application in 2025
11.3.7 Terumo Straight Tube Thoracic Aortic Stent Graft System Sales by Geographic Area in 2025
11.3.8 Terumo Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
11.3.9 Terumo Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Corporation Information
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.4.4 Cook Medical Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Cook Medical Straight Tube Thoracic Aortic Stent Graft System Sales by Product in 2025
11.4.6 Cook Medical Straight Tube Thoracic Aortic Stent Graft System Sales by Application in 2025
11.4.7 Cook Medical Straight Tube Thoracic Aortic Stent Graft System Sales by Geographic Area in 2025
11.4.8 Cook Medical Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
11.4.9 Cook Medical Recent Developments
11.5 Artivion
11.5.1 Artivion Corporation Information
11.5.2 Artivion Business Overview
11.5.3 Artivion Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.5.4 Artivion Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Artivion Straight Tube Thoracic Aortic Stent Graft System Sales by Product in 2025
11.5.6 Artivion Straight Tube Thoracic Aortic Stent Graft System Sales by Application in 2025
11.5.7 Artivion Straight Tube Thoracic Aortic Stent Graft System Sales by Geographic Area in 2025
11.5.8 Artivion Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
11.5.9 Artivion Recent Developments
11.6 SB-KAWASUMI LABORATORIES
11.6.1 SB-KAWASUMI LABORATORIES Corporation Information
11.6.2 SB-KAWASUMI LABORATORIES Business Overview
11.6.3 SB-KAWASUMI LABORATORIES Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.6.4 SB-KAWASUMI LABORATORIES Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 SB-KAWASUMI LABORATORIES Recent Developments
11.7 MicroPort Endovascular MedTech
11.7.1 MicroPort Endovascular MedTech Corporation Information
11.7.2 MicroPort Endovascular MedTech Business Overview
11.7.3 MicroPort Endovascular MedTech Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.7.4 MicroPort Endovascular MedTech Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 MicroPort Endovascular MedTech Recent Developments
11.8 APT Medical
11.8.1 APT Medical Corporation Information
11.8.2 APT Medical Business Overview
11.8.3 APT Medical Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.8.4 APT Medical Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 APT Medical Recent Developments
11.9 LifeTech Scientific Corporation
11.9.1 LifeTech Scientific Corporation Corporation Information
11.9.2 LifeTech Scientific Corporation Business Overview
11.9.3 LifeTech Scientific Corporation Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.9.4 LifeTech Scientific Corporation Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 LifeTech Scientific Corporation Recent Developments
11.10 Beijing Percutek Therapeutics
11.10.1 Beijing Percutek Therapeutics Corporation Information
11.10.2 Beijing Percutek Therapeutics Business Overview
11.10.3 Beijing Percutek Therapeutics Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.10.4 Beijing Percutek Therapeutics Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Beijing Percutek Therapeutics Recent Developments
11.11 Aortec Medical Technology
11.11.1 Aortec Medical Technology Corporation Information
11.11.2 Aortec Medical Technology Business Overview
11.11.3 Aortec Medical Technology Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.11.4 Aortec Medical Technology Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Aortec Medical Technology Recent Developments
11.12 Shanghai INT Medical Instruments
11.12.1 Shanghai INT Medical Instruments Corporation Information
11.12.2 Shanghai INT Medical Instruments Business Overview
11.12.3 Shanghai INT Medical Instruments Straight Tube Thoracic Aortic Stent Graft System Product Models, Descriptions and Specifications
11.12.4 Shanghai INT Medical Instruments Straight Tube Thoracic Aortic Stent Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Shanghai INT Medical Instruments Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Straight Tube Thoracic Aortic Stent Graft System Industry Chain
12.2 Straight Tube Thoracic Aortic Stent Graft System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Straight Tube Thoracic Aortic Stent Graft System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Straight Tube Thoracic Aortic Stent Graft System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Straight Tube Thoracic Aortic Stent Graft System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Straight Tube Thoracic Aortic Stent Graft System Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Proximal Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Region (US$ Million), 2021-2026
Table 7. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Region (US$ Million), 2027-2032
Table 8. Global Straight Tube Thoracic Aortic Stent Graft System Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Straight Tube Thoracic Aortic Stent Graft System Sales by Region (K Units), 2021-2026
Table 10. Global Straight Tube Thoracic Aortic Stent Graft System Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Straight Tube Thoracic Aortic Stent Graft System Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Straight Tube Thoracic Aortic Stent Graft System Sales Share by Manufacturers (2021-2026)
Table 14. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Straight Tube Thoracic Aortic Stent Graft System Revenue, 2025
Table 18. Global Straight Tube Thoracic Aortic Stent Graft System Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Straight Tube Thoracic Aortic Stent Graft System Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Straight Tube Thoracic Aortic Stent Graft System Manufacturing Base and Headquarters
Table 21. Global Straight Tube Thoracic Aortic Stent Graft System Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Type (K Units), 2021-2026
Table 25. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Type (K Units), 2027-2032
Table 26. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Type (US$ Million), 2021-2026
Table 27. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Type (US$ Million), 2027-2032
Table 28. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Proximal Structure (K Units), 2021-2026
Table 29. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Proximal Structure (K Units), 2027-2032
Table 30. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Proximal Structure (US$ Million), 2021-2026
Table 31. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Proximal Structure (US$ Million), 2027-2032
Table 32. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Diameter (K Units), 2021-2026
Table 33. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume by Diameter (K Units), 2027-2032
Table 34. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Diameter (US$ Million), 2021-2026
Table 35. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Diameter (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Straight Tube Thoracic Aortic Stent Graft System Sales by Application (K Units), 2021-2026
Table 38. Global Straight Tube Thoracic Aortic Stent Graft System Sales by Application (K Units), 2027-2032
Table 39. Straight Tube Thoracic Aortic Stent Graft System High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Application (US$ Million), 2021-2026
Table 41. Global Straight Tube Thoracic Aortic Stent Graft System Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Straight Tube Thoracic Aortic Stent Graft System Growth Accelerators and Market Barriers
Table 45. North America Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Straight Tube Thoracic Aortic Stent Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Straight Tube Thoracic Aortic Stent Graft System Growth Accelerators and Market Barriers
Table 48. Europe Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Straight Tube Thoracic Aortic Stent Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Growth Accelerators and Market Barriers
Table 53. Southeast Asia Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Straight Tube Thoracic Aortic Stent Graft System Investment Opportunities and Key Challenges
Table 55. Central and South America Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Medtronic Corporation Information
Table 59. Medtronic Description and Major Businesses
Table 60. Medtronic Product Models, Descriptions and Specifications
Table 61. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Medtronic Sales Value Proportion by Product in 2025
Table 63. Medtronic Sales Value Proportion by Application in 2025
Table 64. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 65. Medtronic Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
Table 66. Medtronic Recent Developments
Table 67. W. L. Gore & Associates Corporation Information
Table 68. W. L. Gore & Associates Description and Major Businesses
Table 69. W. L. Gore & Associates Product Models, Descriptions and Specifications
Table 70. W. L. Gore & Associates Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. W. L. Gore & Associates Sales Value Proportion by Product in 2025
Table 72. W. L. Gore & Associates Sales Value Proportion by Application in 2025
Table 73. W. L. Gore & Associates Sales Value Proportion by Geographic Area in 2025
Table 74. W. L. Gore & Associates Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
Table 75. W. L. Gore & Associates Recent Developments
Table 76. Terumo Corporation Information
Table 77. Terumo Description and Major Businesses
Table 78. Terumo Product Models, Descriptions and Specifications
Table 79. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Terumo Sales Value Proportion by Product in 2025
Table 81. Terumo Sales Value Proportion by Application in 2025
Table 82. Terumo Sales Value Proportion by Geographic Area in 2025
Table 83. Terumo Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
Table 84. Terumo Recent Developments
Table 85. Cook Medical Corporation Information
Table 86. Cook Medical Description and Major Businesses
Table 87. Cook Medical Product Models, Descriptions and Specifications
Table 88. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Cook Medical Sales Value Proportion by Product in 2025
Table 90. Cook Medical Sales Value Proportion by Application in 2025
Table 91. Cook Medical Sales Value Proportion by Geographic Area in 2025
Table 92. Cook Medical Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
Table 93. Cook Medical Recent Developments
Table 94. Artivion Corporation Information
Table 95. Artivion Description and Major Businesses
Table 96. Artivion Product Models, Descriptions and Specifications
Table 97. Artivion Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Artivion Sales Value Proportion by Product in 2025
Table 99. Artivion Sales Value Proportion by Application in 2025
Table 100. Artivion Sales Value Proportion by Geographic Area in 2025
Table 101. Artivion Straight Tube Thoracic Aortic Stent Graft System SWOT Analysis
Table 102. Artivion Recent Developments
Table 103. SB-KAWASUMI LABORATORIES Corporation Information
Table 104. SB-KAWASUMI LABORATORIES Description and Major Businesses
Table 105. SB-KAWASUMI LABORATORIES Product Models, Descriptions and Specifications
Table 106. SB-KAWASUMI LABORATORIES Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. SB-KAWASUMI LABORATORIES Recent Developments
Table 108. MicroPort Endovascular MedTech Corporation Information
Table 109. MicroPort Endovascular MedTech Description and Major Businesses
Table 110. MicroPort Endovascular MedTech Product Models, Descriptions and Specifications
Table 111. MicroPort Endovascular MedTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. MicroPort Endovascular MedTech Recent Developments
Table 113. APT Medical Corporation Information
Table 114. APT Medical Description and Major Businesses
Table 115. APT Medical Product Models, Descriptions and Specifications
Table 116. APT Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. APT Medical Recent Developments
Table 118. LifeTech Scientific Corporation Corporation Information
Table 119. LifeTech Scientific Corporation Description and Major Businesses
Table 120. LifeTech Scientific Corporation Product Models, Descriptions and Specifications
Table 121. LifeTech Scientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. LifeTech Scientific Corporation Recent Developments
Table 123. Beijing Percutek Therapeutics Corporation Information
Table 124. Beijing Percutek Therapeutics Description and Major Businesses
Table 125. Beijing Percutek Therapeutics Product Models, Descriptions and Specifications
Table 126. Beijing Percutek Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Beijing Percutek Therapeutics Recent Developments
Table 128. Aortec Medical Technology Corporation Information
Table 129. Aortec Medical Technology Description and Major Businesses
Table 130. Aortec Medical Technology Product Models, Descriptions and Specifications
Table 131. Aortec Medical Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Aortec Medical Technology Recent Developments
Table 133. Shanghai INT Medical Instruments Corporation Information
Table 134. Shanghai INT Medical Instruments Description and Major Businesses
Table 135. Shanghai INT Medical Instruments Product Models, Descriptions and Specifications
Table 136. Shanghai INT Medical Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Shanghai INT Medical Instruments Recent Developments
Table 138. Key Raw Materials Distribution
Table 139. Raw Materials Key Suppliers
Table 140. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 141. Milestones in Production Technology Evolution
Table 142. Distributors List
Table 143. Market Trends and Market Evolution
Table 144. Market Drivers and Opportunities
Table 145. Market Challenges, Risks, and Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources

List of Figures
Figure 1. Straight Tube Thoracic Aortic Stent Graft System Product Picture
Figure 2. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Polyester Product Picture
Figure 4. ePTFE Product Picture
Figure 5. Other Product Picture
Figure 6. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Proximal Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Covered Stent With Bare Segments Product Picture
Figure 8. Covered Stent Without Bare Segments Product Picture
Figure 9. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Diameter<30mm Product Picture
Figure 11. Diameter 30-40mm Product Picture
Figure 12. Diameter>40mm Product Picture
Figure 13. Global Straight Tube Thoracic Aortic Stent Graft System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Thoracic Aortic Aneurysm
Figure 15. Stanford B-Type Aortic Dissection
Figure 16. Traumatic Injury of Thoracic Aorta
Figure 17. Aortic Intramural Hematoma
Figure 18. Other
Figure 19. Straight Tube Thoracic Aortic Stent Graft System Report Years Considered
Figure 20. Global Straight Tube Thoracic Aortic Stent Graft System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 22. Global Straight Tube Thoracic Aortic Stent Graft System Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 23. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Region (2021-2032)
Figure 24. Global Straight Tube Thoracic Aortic Stent Graft System Sales (K Units), 2021-2032
Figure 25. Global Straight Tube Thoracic Aortic Stent Graft System Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 26. Global Straight Tube Thoracic Aortic Stent Graft System Sales Market Share by Region (2021-2032)
Figure 27. Top 5 and Top 10 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Volume Market Share in 2025
Figure 28. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share Ranking (2025)
Figure 29. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 30. Polyester Revenue-Based Market Share by Manufacturer in 2025
Figure 31. ePTFE Revenue-Based Market Share by Manufacturer in 2025
Figure 32. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume-Based Market Share by Type (2021-2032)
Figure 34. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Type (2021-2032)
Figure 35. Global Straight Tube Thoracic Aortic Stent Graft System ASP by Type (US$/Unit), 2021-2032
Figure 36. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume-Based Market Share by Proximal Structure (2021-2032)
Figure 37. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Proximal Structure (2021-2032)
Figure 38. Global Straight Tube Thoracic Aortic Stent Graft System ASP by Proximal Structure (US$/Unit), 2021-2032
Figure 39. Global Straight Tube Thoracic Aortic Stent Graft System Sales Volume-Based Market Share by Diameter (2021-2032)
Figure 40. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Diameter (2021-2032)
Figure 41. Global Straight Tube Thoracic Aortic Stent Graft System ASP by Diameter (US$/Unit), 2021-2032
Figure 42. Global Straight Tube Thoracic Aortic Stent Graft System Sales Market Share by Application (2021-2032)
Figure 43. Global Straight Tube Thoracic Aortic Stent Graft System Revenue-Based Market Share by Application (2021-2032)
Figure 44. Global Straight Tube Thoracic Aortic Stent Graft System ASP by Application (US$/Unit), 2021-2032
Figure 45. North America Straight Tube Thoracic Aortic Stent Graft System Sales YoY (K Units), 2021-2032
Figure 46. North America Straight Tube Thoracic Aortic Stent Graft System Revenue YoY (US$ Million), 2021-2032
Figure 47. North America Top 5 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) in 2025
Figure 48. North America Straight Tube Thoracic Aortic Stent Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 49. North America Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. US Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 51. Canada Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 52. Mexico Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 53. Europe Straight Tube Thoracic Aortic Stent Graft System Sales YoY (K Units), 2021-2032
Figure 54. Europe Straight Tube Thoracic Aortic Stent Graft System Revenue YoY (US$ Million), 2021-2032
Figure 55. Europe Top 5 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) in 2025
Figure 56. Europe Straight Tube Thoracic Aortic Stent Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 57. Europe Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 58. Germany Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 59. France Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 60. U.K. Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 61. Italy Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 62. Russia Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 63. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Sales YoY (K Units), 2021-2032
Figure 64. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Revenue YoY (US$ Million), 2021-2032
Figure 65. Asia-Pacific Top 8 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) in 2025
Figure 66. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 67. Asia-Pacific Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. Indonesia Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 69. Japan Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 70. South Korea Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 71. China Taiwan Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 72. India Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 73. Central and South America Straight Tube Thoracic Aortic Stent Graft System Sales YoY (K Units), 2021-2032
Figure 74. Central and South America Straight Tube Thoracic Aortic Stent Graft System Revenue YoY (US$ Million), 2021-2032
Figure 75. Central and South America Top 5 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) in 2025
Figure 76. Central and South America Straight Tube Thoracic Aortic Stent Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 77. Central and South America Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 78. Brazil Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 79. Argentina Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 80. Middle East, and Africa Straight Tube Thoracic Aortic Stent Graft System Sales YoY (K Units), 2021-2032
Figure 81. Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Revenue YoY (US$ Million), 2021-2032
Figure 82. Middle East and Africa Top 5 Manufacturers Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) in 2025
Figure 83. Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 84. Middle East and Africa Straight Tube Thoracic Aortic Stent Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 85. GCC Countries Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 86. Turkey Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 87. Egypt Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 88. South Africa Straight Tube Thoracic Aortic Stent Graft System Revenue (US$ Million), 2021-2032
Figure 89. Straight Tube Thoracic Aortic Stent Graft System Industry Chain Mapping
Figure 90. Regional Straight Tube Thoracic Aortic Stent Graft System Manufacturing Base Distribution (%)
Figure 91. Global Straight Tube Thoracic Aortic Stent Graft System Production Market Share by Region (2021-2032)
Figure 92. Straight Tube Thoracic Aortic Stent Graft System Production Process
Figure 93. Regional Straight Tube Thoracic Aortic Stent Graft System Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed